Thrombospondin 1 (TSP-1) is a multifunctional extracellular matrix protein that is an endogenous regulator of tumor angiogenesis. The effects of TSP-1 on adenoma formation and development into cancerous lesions has been evaluated in the Min /⍣ (multiple intestinal neoplasia) mouse model. These mice develop multiple adenomas in the small intestine due to a mutation in the homologous APC (adenomatous polyposis coli) gene. As in its human counterpart, these adenomas may progress to carcinomas. Intestines of APC Min/⍣ mice were dissected and histologic evaluation of adenomas was then conducted. Significant increases in vascularization and proliferation were observed in adenomatous, as compared with normal, mucosa. TSP-1 immunostaining revealed significant decreases in the number and intensity of positive cells in adenomas, as compared with normal mucosa. TSP-1 scores were inversely correlated with vascularity and proliferation rate. Cross breeding of mice homozygous for a deletion of the TSP-1 gene (TSP-1 -/-) with mice heterozygous for the APC gene mutation (APC Min/⍣ ), resulted in animals that showed a significant increase in adenoma number and diameter. Also, histopathological examination of these adenomas showed accelerated dysplasic changes, carcinoma in situ and early invasion, compared with their APC Min/⍣ littermates. Moreover, a significant decrease of TUNEL-positive cells was observed in intestinal adenomas of TSP-1 -/-/APC Min/⍣ mice. This study reports the first in vivo impact of TSP-1 during early stages of tumor initiation and development in an intestinal carcinogenesis model and demonstrates that TSP-1 affects both angiogenesis and tumor cell apoptosis.
Introduction
Recognition of the role of angiogenic regulators during neoplastic development is important for a more complete understanding of the mechanisms involved in tumor growth and metastasis. One class of such regulators is represented by the thrombospondins. Thrombospondin (TSP)-1 and TSP-2 are large multifunctional structurally similar proteins secreted by activated platelets and other types of cells (1, 2) . TSP-3, TSP-4 and cartilage oligomeric protein belong to a separate TSP subgroup and possess structural homologies with TSP-1 and TSP-2 in their C-terminal segments.
While structurally homologous, the spatial and temporal expression of the mRNAs for TSP-1 and TSP-2, as well as the types of proteins with which they interact, suggest that both similarities and differences exist in their functions (3) (4) (5) (6) (7) . Accordingly, TSP-1 and TSP-2 are believed to possess important functions in embryonic development, cell growth and proliferation, tissue remodeling, wound healing, inflammation and fibrinolysis (1, (8) (9) (10) (11) (12) . TSP-1 and TSP-2 are also involved in regulation of angiogenesis, as well as tumor progression and metastasis, perhaps due to the inverse correlation between TSP-1 and TSP-2 mRNA levels and bFGF expression (13) ; to the up regulation of TSP-1 expression by the product of the wild-type (WT) tumor suppressor gene, p53 (14); to their inhibition of endothelial cell proliferation (15) ; and/or to their induction of receptor-mediated apoptosis in activated microvascular endothelial cells (16) . Despite this, the roles of TSP-1 and TSP-2 in neoplasia remain controversial. On one hand, higher levels of TSP-1 have been detected in plasmas of patients with a variety of cancers (17) , including breast cancer (18) . Additionally, in a murine metastasis model, TSP has been shown to promote metastasis of fibrosarcoma tumor cells to the lung (19) . However, other in vitro and in vivo studies have demonstrated inhibitory functions for TSP-1 and TSP-2 (20) (21) (22) (23) (24) (25) (26) (27) , as well as the TSP-1 receptor (28) , in vessel formation, tumor angiogenesis and metastatic potential; properties that should attenuate progression of the tumor. In addition, it has been found that TSP-1 expression is reduced in carcinomas of the colon (29) , breast (30) and bladder (31) . Moreover, evidence has been presented indicating that activation of the proangiogenic factor, VEGF (vascular endothelial growth factor), occurs in the pre-malignant phase of colorectal tumor development (25) , and the switch to an angiogenic phenotype may in part be the result of down regulation of inhibitors, such as TSP-1 (27) .
In the current investigation, the relationships between TSP-1 expression and colorectal tumor progression have been assessed using the APC Min/ϩ mouse model (a mouse heterozygous for a chain-termination mutation in the 15th exon of the APC gene) that develop multiple intestinal adenomas that clinically mimic those observed in patients with familial adenomatous polyposis (32) . These adenomas undergo early transformation into colon carcinomas. The effects of TSP-1 on adenoma growth and progression to carcinomas were also examined by cross breeding mice with a genetic total deficiency of TSP-1 (TSP-1 -/-) with APC Min/ϩ mice. The results are summarized in the current communication.
Materials and methods
Mice and tissue preparation APC Min/ϩ male mice were purchased from the Jackson Laboratory (Bar Harbor, ME). TSP-1 -/-mice were generated as described (33) . Mice were maintained on an 11% fat diet, as were their littermate controls. After 90 or 120 days, the animals were killed using CO 2 asphyxiation. Immediately at Pennsylvania State University on February 23, 2013 http://carcin.oxfordjournals.org/ Downloaded from thereafter, the whole intestine was exposed and rinsed with a buffer consisting of 10 mM phosphate, 0.15 M NaCl, pH 7.5 (PBS). The tissue was fixed with 6% formalin in PBS for 6 h, then embedded in paraffin. Sections (3 µm) were stained with H&E (hematoxylin-eosin) and also subjected to immunohistochemical analysis (4 µm).
Adenoma scoring
Small intestinal adenomas and colonic adenomas were scored for numbers and diameters at postnatal days 75 or 150 for the cross between APC Min/ϩ (n ϭ 13) and APC Min/ϩ /TSP-1 -/-(n ϭ 7), respectively. The small intestines and colons were dissected free of mesentery and opened along the longitudinal axis. Intestinal contents were cleared with PBS. The intestines were fixed in 6% formalin/PBS for 6 h, followed by 70% ethanol. Using a dissecting microscope (X10-30) and digital calipers, adenoma numbers and diameters were obtained for the entire length of the small intestine and colon. Adenoma analyses were performed without any knowledge of genotype by a pathologist (M.S.) and confirmed independently by another (L.G.) Histology and immunohistochemistry Colon samples and small intestine segments were paraffin-embedded and sectioned. Stained sections were viewed without knowledge of genotypes and evaluated by an independent pathologist (Dr Luis Galup, South Bend Medical Foundation, South Bend, IN). All adenomas were checked by H&E and changes such as carcinoma in situ and stromal invasion were evaluated. Adenomas were characterized by expansion of the mucosa layer, reduction in goblet cell number, moderate loss of mucosal architecture by glandular growth and dilated cysts. Only non-lymphoid adenomas were evaluated. Adenomas with Ͼ50% of high-grade dysplasia (severe distortion of the glandular architecture and prominent cellular atypia) were considered carcinomas in situ. However, only the lesions showing invasion through the muscularis mucosa were identified as carcinomas. Sections for immunohistochemistry were cleared with xylene and rehydrated by ethanol. Endogenous peroxidase was blocked with peroxyblock (Zymed, San Francisco, CA). Sections designated for TSP-1 and vWF (von Willebrand Factor) immunostaining were treated with 0.2% trypsin/PBS at 37°C for 10 min. Slides for PCNA (proliferant cell nuclear antigen) were boiled in 0.01 M citrate buffer solution, pH 6, for 10 min. The sections were incubated overnight at room temperature with monoclonal antibodies against TSP (Ab4, NeoMarkers, Fremont, CA), PCNA (Biogenex, San Ramon, CA) and VEGF (Oncogene Research Products, Boston, MA). The samples were then incubated with biotinylated rabbit antimouse antibody (Vector, Burlingame, CA) for 30 min. After incubation with peroxidase (ABC Kit), the stains were visualized with the chromogen, DAB (3Ј,3-diaminobenzidine; Pierce, Rockford, IL) or AEC (3-amino-9-ethyl carbazole; Vector). For vWF immunohistochemistry, the DAB step was performed immediately after incubation with horseradish peroxidasecomplexed anti-vWF antibody (DAKO EPOS, Carpinteria, CA). TUNEL The TUNEL assay was performed according to a published method (34) . Tissue sections were incubated with 5 µg/ml of proteinase K for 15 min at room temperature in order to digest proteins. Sections were then covered with a buffer containing 30 mM Tris-HCl, pH 7.2/140 mM sodium cacodylate/1 mM CoCl 2 . An aliquot of 0.2 µl of terminal deoxynucleotidyl-transferase (Boehringer Mannheim, Gaithersburg, MD) and 10 µM biotinylated dUTP (Boerhringer Mannheim) were added to the sections. The slides were incubated in a humidified chamber at 37°C for 60 min, washed with 50 mM Tris-HCl, pH 7, and finally with PBS. The sections were then incubated for 30 min with the ABC system and DAB was used as the chromogen. Data analyses TSP-1 and VEGF stainings were scored in a semiquantitative fashion, incorporating both the intensity and the distribution of specific staining. The evaluations were recorded as the percentage of positive stained cells in each of four categories: 0 (no staining), 1ϩ (weak), 2ϩ (distinct) and 3ϩ (intense). 
Statistical methods
Non-parametric ANOVA and Fisher's tests were used. P values Ͻ0.05 were considered significant. The correlations between Hscore of TSP-1, MVC and PCNA indexes were calculated using the Fisher t-test for paired comparisons.
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Results
Immunohistochemistry of lesions in the APC Min/ϩ mouse
Normal intestinal mucosa from colon and small intestine revealed strong staining for TSP-1. This stain was diffuse and present mainly in the lamina propria ( Figure 1A and B). Endothelial cells, fibroblasts and granulocytes showed strong cytoplasmic and membranous immunoreactivity. Staining was also observed in the submucosa and in large vessels of the intestinal wall, as well as in platelets. Positive staining was rarely observed in epithelial cells and, when present, was weak and scattered. This staining pattern also has been described in other types of carcinomas, e.g. squamous cell (30) and breast (35) carcinomas. In general, TSP-1 immunostaining pattern in non-polypoid areas of APC Min/ϩ intestines ( Figure 1A and B) and WT intestines was similar. However, segments of APC Min/ϩ intestine occasionally showed a progressive decrease in staining ( Figure 1C , arrows), while fully developed adenomas were almost negative for TSP-1. Only scattered epithelial cells were weakly positive ( Figure 1D ). HScores were obtained evaluating the number of positive cells and staining intensity in intestines from WT mice as well as non-polypoid (normal intestine) and adenomas from APC Min/ϩ . No significant differences in TSP-1 expression were observed between intestines from WT mice and non-polypoid areas of intestines from APC Min/ϩ . However, adenomas demonstrated significantly lower Hscore indices compared with WT and normal mucosa from APC Min/ϩ ( Figure 2A ). The TSP-1 null intestine was employed as a control for the specificity of the antibody (data not shown). In this case, TSP immunohistochemistry showed a complete lack of immunostain in the stroma, endothelial cells and platelets. Only plasmocytes in the lamina propria and plasma in some vessels of the submucosa displayed weak staining. While some mild cross reactivity with TSP-2 has been reported for this antibody by the manufacturer, our immunostaining of intestines of TSP-1 -/-mice showed the weak staining pattern outlined above. However, the typical TSP-1 staining in the stroma, macrophages, fibroblasts, platelets and endothelial cells of WT mice was absent in TSP-1 -/-mice, suggesting that the antibody was suitable for the purposes of the experiments within this report.
vWF immunostaining revealed an increased number of vessels in the polyp areas ( Figure 1E ), compared with normal intestine ( Figure 1F ). These vessels were very small and round, with enlarged endothelial cells. Capillaries were observed mainly at the tops of the adenomas. An inverse relationship was clearly observed when vascularity and proliferation were correlated with the TSP-1 score of the intestinal tissues. Here, MVC were significantly higher in areas with decreased TSP-1 immunostains ( Figure 2B ). In addition, the polyps showed higher PCNA indices ( Figure 2C ). Moreover, when TSP-1 scores were compared with PCNA indices, areas of higher proliferation rate showed lower TSP-1 scores. These results demonstrate that TSP-1 is expressed in normal intestinal tissue, and may help to maintain equilibrium in the normal vasculature. The differential expression between normal and adenomatous mucosa may indicate that TSP-1 is an important regulator in early stages of intestinal carcinogenesis. When TSP-1 is down regulated, a more favored environment for intestinal angiogenesis and proliferation is established that may contribute to initiation of the adenoma-carcinoma sequence. In this regard, this work, as well as other studies (20) (21) (22) (23) (24) (25) (26) (27) , has demonstrated an inverse correlation between TSP-1 expression and tumor vascularity and survival. There is evidence as well of increased vascularity and angiogenic factors, such as VEGF, in human adenomas (36, 37) .
VEGF immunostaining of normal ( Figure 1G ) and adenomatous ( Figure 1H ) mouse intestine shows that VEGF is clearly present in both samples, but demonstrates a somewhat different expression pattern with variability between regions of the intestine. VEGF is expressed mainly in the proliferative zones of the crypts in normal intestine ( Figure 1G ). Immunoreactivity of the glandular epithelium decreases gradually from the bases of the crypts to the luminal surfaces. In adenomas (Figure 1H ), the strongest cytoplasmic staining was present in the epithelial cells of the mucosal surface. The increase in VEGF intensity at the tops of the adenomas correlate with higher areas of vascularity.
The data obtained suggest that the down regulation of TSP-1 in the mature adenoma ( Figure 1D) , coupled with the presence of VEGF (Figure 1H ), shifts the balance toward neovascularization that would be stimulated by VEGF. These observations offer an explanation of the vascularization seen in the adenoma in Figure 1E . However, in normal tissue, the 201 presence of TSP-1 ( Figure 1A and B) would inhibit the angiogenic tendency of the VEGF observed in Figure 1G , thus producing the lack of neovessels in Figure 1F . Thus, a regulatory switch in TSP-1 levels may play a role in angiogenic changes of normal and adenomatous tissue leading to carcinogenesis of intestinal polyps.
General features of APC Min/ϩ /TSP -/-mice
Because of the relationships suggested above between TSP-1 levels and angiogenesis, TSP-1-deficient mice were crossed with mice to generate APC Min/ϩ /TSP-1 -/-mice in order to more directly assess the role of TSP-1 in this genetic model of colonic carcinogenesis. The APC Min/ϩ /TSP-1 -/-mice showed the characteristic lordotic spine curvature observed in TSP-1 -/-mice (33). They rapidly developed anemia (extremely pale skin and internal organs), bloody feces and weight loss. They expired earlier than their controls (one mouse died from severe anemia before 30 days and one died before 90 days). For this reason, most of the APC Min/ϩ /TSP-1 -/-mice were killed before 90 days after birth. No mammary, skin or stomach tumors were observed. 
Adenoma counts and diameters in APC Min/ϩ and APC Min/ϩ / TSP-1 -/-mice
Mean adenoma counting revealed a significant increase (P ϭ 0.037) in adenoma number in APC Min/ϩ /TSP-1 -/-mice (39 adenomas, n ϭ 7), compared with APC Min/ϩ control littermates (25 adenomas, n ϭ 13) ( Figure 3A-C) . Whereas the differences in the adenoma diameters were not statistically significant (P ϭ 0.54), adenomas in APC Min/ϩ /TSP-1 -/-mice tended to be larger (3.6 mm) compared with their controls (2.1 mm).
Histopathological evaluation of colonic adenomas from APC Min/ϩ /TSP-1 -/-mice
Each tissue section stained with H&E was evaluated. Features, such as dysplasic changes, carcinoma in situ and stromal 202 Figure 4B and E), intense leukocytic infiltrate, and complete loss of glandular and nuclear polarity ( Figure 4B , C, E and F). Carcinoma in situ was present in almost all the lesions, even those that were smaller ( Figure 4C) . Also, thickening of the walls, glandular invasion of the muscularis and venous embolism were more frequently seen in APC Min/ϩ /TSP-1 -/-mice ( Figure 4F ). TSP -/-littermate intestines were also evaluated. Intestinal mucosa of these mice showed some evidence of greater epithelial proliferation, increased mucosal depth growth and villi diameters (data not shown).
Vascularity in adenomas of APC Min/ϩ /TSP-1 -/-mice
As TSP-1 is an anti-angiogenic agent, a higher number of vessels in mice lacking TSP-1 was expected. No significant differences were observed between APC Min/ϩ (vascularity in adenomas, 22.3; vascularity in carcinomas, 29.4) and APC Min/ϩ /TSP-1 -/-(vascularity in adenomas, 21.1; vascularity in carcinomas, 27.5) mice. As it has been reported, an increase in angiogenesis was observed in the transition of normaladenoma to carcinoma in both genotypes, but the vessel counts were similar between both groups (data not shown). Apoptotic indices TSP-1 induces apoptosis in endothelial cells and is up regulated by p53 (29) . As p53 is a major regulator of apoptosis, we examined in situ apoptosis in APC Min/ϩ /TSP-1 -/-mice using the TUNEL assay. Apoptotic indices were significantly lower in adenomas and carcinoma of APC Min/ϩ /TSP-1 -/-mice (adenomas, 4. compared with carcinomas and lesions developed in APC Min/ϩ /TSP-1 -/-mice ( Figure 6E ). These results indicate that higher proliferation and accelerated carcinogenesis are typical features in the lesions which arose in APC Min/ϩ /TSP-1 -/-mice, and even smaller adenomas showed elevated PCNA indices. The latter may be the result of the behavior of malignant cell clones, which eventually will display a more aggressive and invasive phenotype. VEGF immunohistochemistry VEGF immunostaining was observed in the endothelial cells lining vessels of normal intestine and adenomas. The stain was more intense in the normal colonic mucosa. In contrast to the normal mucosa, adenomas showed a variable intensity, with focal areas of epithelial cells usually strongly positive. The stroma of the lamina propria was positive for VEFG in both groups, and this staining was usually confined to the top area of the adenoma, where vessels and stroma were usually positive. In general, no clear differences in intensity and localization were observed between APC Min/ϩ /TSP-1 -/-and APC Min/ϩ mice.
Discussion
The aim of this study was to evaluate the importance of the angiogenic inhibitor TSP-1 in naturally occurring tumors in vivo. As an indicator of the value of this approach, it has been demonstrated that mice with a deficiency of the tumor suppressor gene, p53, showed decreased survival with an additional deficiency of the TSP-1 gene (38) . In our case, using an animal model for intestinal adenomatosis, we report the immunolocalization of TSP-1 in normal and pre-malignant intestine. Evidence is presented of a decrease of TSP-1 expression in adenomas and its inverse relationship with more proliferative and vascularized intestine.
On the other hand, no significant differences in vascularization between adenomas and carcinomas in APC Min/ϩ and all lesions of APC Min/ϩ /TSP-1 -/-mice were found. These adenomas, already dysplastic, ultimately become carcinomas, and perhaps no additional vascularization beyond that found in the adenomas is required for the transformation, thus providing a basis for the lack of differences found in adenoma 204 and carcinoma vascularization. These results suggest that TSP-1 may be required in the initial stages of angiogenesis when the vascular supply is low. However, when angiogenesis in the tumor is well established, endogenous TSP-1 has less influence. It is possible that during carcinogenesis, specific clones of cells, less dependent on vessel supply and more resistant to hypoxia, overgrow (39) . Therefore, at this stage, vascular supply and angiogenic regulators may play a more secondary role. Also, angiogenesis may be genetically driven (40) , and tumor cells at later time points may self-determine their vascular microenvironment. These findings may explain recent reports showing that the efficiency of anti-angiogenic therapy is related to the type, size and location of the tumor (41) . Alternatively, TSP-1 is not the only inhibitor of angiogenesis, since other anti-angiogenic factors, e.g. angiostatin and TSP-2, could be produced after the onset of tumor development.
Our results further show TSP-1 to have properties beyond its anti-angiogenic effects. APC Min/ϩ mice, additionally lacking the TSP-1 gene, were more tumorigenic, indicating that this combination of altered genes leads to a more malignant phenotype. TSP-1 is a complex protein, with the ability to interact with a number of pro-apoptotic and growth factors. Its interactions with these proteins in the tumor microenvironment may regulate apoptosis and proliferation, not only in neovessels, but also in malignant epithelial cells. TSP-1 regulates activation of endogenous proteins, including TGF-β (40, 41) , which is involved in multiple pathological events, such as wound healing, proliferation and tumor angiogenesis (42) . Also, the loss of tumor suppressor genes may decrease TSP-1 expression and lead to an angiogenic phenotype in tumors (43) .
Other studies have indicated that TGF-β RII expression is diminished in intestinal adenomas of APC Min/ϩ mice with an associated increase in cyclin D1 and cyclin-dependent kinase 4 (Cdk4) expression, which would facilitate cell proliferation and progression of the disease (44) . Additionally, a mutation in the APC gene induces nuclear expression of β-catenin, which is involved in E-cadherin-mediated cell adhesion and is also a key effector of the prooncogenic Wnt signaling pathway. This latter property has been suggested as a potential cause of development of carcinoma from adenoma in colorectal carcinoma (45) . Catenin accumulation induces activation of proliferation-associated genes, cyclin D and c-myc, and the invasion-associated genes, MMP-1 and MMP-7 (46) . TSP-1 may be additionally involved in this pathway as it modulates tumor cell adhesion (47) and also induces increased levels of members of the catenin family, e.g. γ-catenin and p120 (Cas), in endothelial cells (48) . Of potential importance is the observation that TSP-1 increases the secretion of protease inhibitor PAI-1 (49), which has been reported as a regulator of angiogenesis and tumor growth potentially via its effects on VEGF expression (50) . Additionally, TSP-1 is up regulated by the WT product of the P53 gene (51) . This induction by p53 may cause tumor cell apoptosis thus directly or indirectly inhibiting tumor angiogenesis.
Numerous reports have shown that high TSP-1 expression in human cancers appears to be a good prognostic factor (52) (53) (54) . The clinical data, as well as some animal data, emphasize the role of TSP-1 as a protective factor against cancer and a strong modulator of tumorigenesis (38) . This has been further reinforced in studies of a spontaneous mammary tumor model (transgenic neu/erbB2 oncogene under control of the mouse mammary tumor virus) with an additional deficiency or over- enhances tumorigenesis by regulating proliferation and apoptosis, and accelerating the transformation of adenomas to carcinomas. Tumor apoptosis and vascularity are the main outcome predictors in many tumors. These findings are relevant as they highlight the dual properties of TSP-1 as an early antiangiogenic and pro-apoptotic agent, making it a potential powerful tool against colorectal cancer. Lastly, the presence of early gene mutations, and/or environmental factors, may affect TSP-1 production and secretion. Down regulation of TSP-1 may play an important role in early events of colonic carcinogenesis, and this should be considered in an overall strategy for delaying polyposis in patients with a genetic predisposition to colorectal carcinoma. Thus, this protein may be a valuable marker of malignant transformation.
